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Summary The records of 610 consecutive patients with small cell lung cancer, treated on a common protocol
in a multicentre trial, were reviewed and 24 (4%) cases of spinal cord compression identified. Five hundred
patients had isotope bone scans performed at presentation, and in 131 (26%) there was abnormal isotope
uptake in the spinal column; only 7% of these patients developed spinal cord compression. However, of the
24 patients who presented with back pain and had a positive bone scan affecting the spine, 36% developed
cord compression. Cerebral metastases occurred at some stage in 19.5% of all patients and in 45% of patients
with cord compression. The combination of cerebral metastases and a positive bone scan gave a 25% chance
of developing spinal cord compression.
There were two distinct forms of clinical presentation. Six patients (group A) presented with cord
compression: All had back pain and positive bone scans, five out of six had sphincter disturbance, and
median survival from cord compression was 30 weeks. Eighteen patients (group B) developed cord
compression while on treatment: 28% had positive initial bone scans, 44% back pain and 61% sphincter
disturbance, and median survival from cord compression was 4 weeks. Spinal cord compression is an
important cause of morbidity and mortality in small cell lung cancer. We suggest that it may be possible to
select patients who should receive radiotherapy to the spine to try to prevent the development of this
complication.
Spinal cord compression is an uncommon but important
complication of metastasis from solid tumours which causes
considerable morbidity. Lung cancer is the most common
primary tumour in such patients, accounting for 20-30% of
cases (Stark et al., 1982; Brice & McKissock, 1965; Young et
al., 1980; Dunn et al., 1980; Marshall & Langfitt, 1977), with
25% histologically of small cell type (Stark et al., 1982). The
incidence of spinal cord compression in patients with small
cell lung cancer (SCLC) is estimated at between 3.5 and 13%
(Pedersen et al., 1985; Posner, 1977; Nugent et al., 1979).
Treatment is often unsatisfactory, with many patients
remaining seriously disabled throughout the illness (Stark et
al., 1982; Young et al., 1980; Dunn et al., 1980; Marshall &
Langfitt, 1977; Pedersen et al., 1985; Posner, 1977; Nugent et
al., 1979; Rodriguez & Dinapoli, 1980). Prevention of this
complication is highly desirable and recognition of patients
at high risk of cord compression could allow early prophy-
lactic treatment with radiotherapy. We performed an analy-
sis of 610 patients with SCLC, treated in a single randomised
trial, with the aim of defining the incidence, clinical features,
predictive factors and prognosis of spinal cord compression.
Patients and methods
Six-hundred and sixteen previously untreated patients were
entered in a multicentre trial of chemotherapy for SCLC
between February 1982 and September 1986 (Spiro et al.,
1987). Six patients were excluded from analysis because of
incorrect diagnosis or second malignancy. Patients were
staged as having local or extensive disease based on clinical
examination, chest X-ray, liver function tests, liver ultra-
sound scan, isotope bone scan and, when clinically indicated,
isotope or CT brain scan and bone marrow aspiration. Local
disease was defined as tumour confined to one hemi-thorax.
Patients were randomised to either four or eight courses of
vincristine, cyclophosphamide and etoposide at 3-weekly
intervals. At relapse they were again randomised to receive
symptomatic treatment only, or further chemotherapy with
adriamycin and methotrexate. The results of this trial are
reported separately (Spiro et al., 1987).
A diagnosis of spinal cord compression was accepted when
there were clearly documented and compatible symptoms
and physical signs. The case records of patients presenting
with back pain as their major symptom and those with
cerebral metastases were examined. The results of all the
bone scans performed during the multicentre trial were
obtained and those suggestive of vertebral metastases
selected. Treatment of cord compression took the form of
laminectomy and decompression of the spinal cord, radio-
therapy (30Gy in 10 fractions) with or without dexametha-
sone 16mg daily, or symptomatic treatment. Effective
treatment was defined as that which rendered the patient
continent and ambulant. During specific treatment for spinal
cord compression, chemotherapy was continued according to
the trial protocol.
Results
Twenty-four patients (4%) had definite evidence of spinal
cord compression at some stage of their disease. There were
20 males (mean age 56 years, range 30-67 years) and four
females (mean age 52 years, range 43-62 years). Twenty of
these patients (83%) were staged as extensive disease at
presentation.
Five hundred patients in the whole trial had bone scans
performed at presentation. Two hundred and thirty-four
(47%) showed abnormal uptake of isotope by bone, and in
131 (26%) this included the spinal column and was sugges-
tive of metastatic disease. The cervical spine alone was
affected in 17 cases, the thoracic or thoracic and lumbar
spine in 61 cases and the lumbo-sacral spine alone in 43
cases. Fourteen patients had positive bone scans at relapse,
nine involving the spinal column.
Of the 24 cases of spinal cord compression (Table I) nine
(37.5%) had positive bone scans at presentation with abnor-
mal isotope uptake in the spinal column. In all of these the
abnormality was located in the thoracic spine. Two other
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Table I Clinical features of patients with cord compression
Group A Group B Whole
(at presentation) (at relapse) trial
Cord 6 18 24
compression
Limited disease - 4 196
(at presentation)
Extensive 6 14 414
disease (at
presentation)
Cerebral 1 3 32
metastases at
presentation
At relapse 3 4 87
Total 4 7 119
(66.5%) (40%) (19.5%)
Bone scans 6 16 500
performed
Abnormal bone 6 5 234
scan (at
presentation)
Abnormal bone 6 5 131
scan affecting (100%) (28%) (21.5%)
vertebrae or
vertebral
collapse on
X-ray
Back pain 6 8
(100%) (44%)
Sphincter 5 11
disturbance (83%) (61%)
patients had not had bone scans because plain X-rays had
shown vertebral collapse at the appropriate level. There were
two further patients with positive bone scans not involving
the spine. The remaining 11 patients had negative bone scans
at presentation. Of these one became positive at relapse.
From the original 610 patients, 24 (4.1%) presented with
back pain and positive bone scans affecting the spinal
column. Of these, nine (36%) developed spinal cord
compression.
Eleven (45%) of the 24 patients with spinal cord compres-
sion had cerebral metastases, four before the onset of cord
compression and seven after the development of their spinal
symptoms (Table I). In the multicentre trial 32 patients
presented with cerebral metastases and a further 87 went on
to develop them, the overall incidence being 19.5%.
The 24 patients with spinal cord compression could be
divided into two groups (Table I). Six patients (25%)
presented with symptoms and signs of cord compression
(group A) while 18 patients (75%) developed this complica-
tion during treatment (group B). The median time for cord
compression to develop after the diagnosis of SCLC was 27
weeks (range 14-97 weeks).
Group A patients all had back pain at presentation, with a
positive bone scan affecting the spinal column or vertebral
collapse on X-ray. Five (83%) patients had sphincter distur-
bance at presentation. In contrast eight (44.5%) of the group
B patients had back pain at relapse. Five (28%) had a
positive bone scan affecting the spine or vertebral collapse
on plain X-ray, two had positive bone scans without abnor-
mality in the spine and 11 had normal bone scans. Sphincter
disturbance was evident in 11 (61%) group B patients.
Only 11 of the 24 patients with spinal cord compression
had myelograms performed. Four were in group A and
seven in group B. Six demonstrated abnormalities in the
thoracic spine, one in the cervical spine, and one in the
lumbar spine, while three were normal.
Treatment and median survival from presentation and
spinal cord compression are shown in Tables II and III.
Three patients underwent surgical decompression of the
spinal cord and radiotherapy. Fourteen patients received
radiotherapy, six in conjunction with dexamethasone. Seven
Table II Management in 24 cases of spinal cord compression due
to small cell lung cancer
Group A Group B
(at presentation) (at relapse) Overall
Myelogram 4 (67%) 7 (39%) 11 (46%)
performed
Surgery and 2 (33.5%) 1 (5.5%) 3 (12.5%)
radiotherapy
Radiotherapy 3 (50%) 11 (61%) 14 (58.5%)
Symptomatic 1 (16.5%) 6 (33.5%) 7 (29%)
patients were given symptomatic treatment only. Overall, six
patients were thought to have improved significantly after
treatment, being ambulant with normal sphincter control.
These consisted of two of the patients treated surgically, and
four from the radiotherapy group.
The median survival of the patients with spinal cord
compression depended on extent of disease at presentation
(Table III, Figure 1). Those with localised disease had a
median survival of 44 weeks (range 6-103) and those with
extensive disease 33 weeks (range 4-57).
Group A had a median survival of 30 weeks from cord
compression and group B four weeks (range 1-17 weeks)
(Table III). The fitter patients were selected for surgery and
survived 17 weeks, 55 weeks and 57 weeks after treatment.
Patients treated with radiotherapy had a median survival of
six weeks (range 1-33 weeks) and treatment with dexametha-
sone did not add a survival advantage. Seriously ill patients
were treated symptomatically and had a median survival of
four weeks (range 1-14 weeks).
Discussion
The incidence of spinal cord compression in patients with
SCLC in this study was 4%, which is similar to that
reported in previous retrospective series (Pedersen et al.,
1985; Nugent et al., 1979). Only six of the 24 patients who
developed cord compression regained ambulance and conti-
nence and median survival from onset of the syndrome was
6 weeks.
We analysed the results of the 500 initial bone scans
performed in the trial in order to assess if a positive bone
scan affecting the spinal column at presentation was a useful
predictive factor for spinal cord compression (Table IV).
Twenty-six per cent of these scans showed increased isotope
uptake in the spine, suggesting metastases. Within this group
nine patients (7%) went on to develop cord compression. A
positive bone scan affecting the spine is thus not a strong
enough predictor of cord compression to merit prophylactic
radiotherapy. However, if pain is also taken into account, of
the 24 patients presenting with back pain and a positive
bone scan affecting the spine, nine (36%) developed cord
compression. In eight of these patients the site of cord
compression coincided with the site of the abnormality on
the bone scan. In current practice, however, isotope bone
scans are used less frequently in the staging of SCLC, but
our data would suggest that they should be undertaken in
patients with back pain. This would allow the identification
of patients with vertebral metastases who may be at risk of
spinal cord compression and indicate the area to which
prophylactic radiotherapy might be directed, in the hope of
preventing cord compression as the fully established syn-
drome responds disappointingly to therapy.
Cerebral metastases occurred in 46% of patients with
spinal cord compression and in 19.5% of the patients in the
trial, confirming the association between metastases from
SCLC in different parts of the central nervous system
(Nugent et al., 1979; Rosen et al., 1982). There were 24
patients who had positive bone scans affecting the spine and
cerebral metastases, six (25%) developed spinal cord com-
pression at the site of abnormal isotope uptake. These riskSPINAL CORD COMPRESSION 593
Table III Median survival in 24 cases of spinal cord compression due to
small cell lung cancer
Group B
Group A (at Whole
(at presentation) relapse) Overall trial
Median survival from presentation (weeks)
All 30 34 33 37
Extensive 30 33 33 32
disease
Local disease - 44 44 49
Median survivalfrom cord compression (weeks)
All 30 4 6 15
Surgery (3 cases 57,55, 17)
Radiotherapy 6
Symptomatic 4
Table IV Predictive factors for spinal cord compres-
sion in small cell lung cancer
Incidence of
cord compression
Patients 610 24 (4%)
Bone scans 500 22 (4.4%)
performed
Bone scan 234 11 (4.7%)
abnormal
Bone scan 131 9 (7%)
abnormality in
spinal column
Presented with 24 9 (36%)
back pain and
abnormal bone
scan
Presented with 32 4 (12.5%)
cerebral
metastases
Relapsed with 87 7 (8%)
cerebral
metastases
All cerebral 119 11 (9.2%)
metastases
Cerebral metastases 24 6 (25%)
and abnormal
bone scan
factors in combination may also merit treatment with
radiotherapy to the spine at the level of the abnormality as
prophylaxis against spinal cord compression.
The 24 patients with spinal cord compression in this series
could be divided into two distinct groups with differing
clinical features and prognosis. Group A, who presented
with cord compression, all had back pain and positive bone
scans or abnormal X-rays affecting the spine. By contrast in
group B, who had relapsed with cord compression, less than
half had back pain and only a quarter had evidence of bone
destruction using the imaging techniques. In group A three
of the four myelograms performed showed a complete block,
while in group B, of the seven myelograms performed four
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Figure 1 Survival from onset of cord compression in groups A
and B.
showed a partial block, one an intra-medullary metastasis
and one a complete block.
The overall median survival of patients in group A was 30
weeks and in group B 34 weeks (Figure 1). However, if
survival is measured from onset of cord compression the two
groups are very different. Group A patients have the same
median survival (30 weeks) while that of group B is 4 weeks.
This poor prognosis in association with the severe morbidity
of the condition leads us to consider the use of prophylactic
radiotherapy to the area of increased isotope uptake in those
who present with back pain and a positive bone scan, and in
those with evidence of cerebral metastases and a positive
bone scan. The aim of this intervention would be to decrease
the incidence of spinal cord compression.
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